Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos Vasquez

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of Translational Medicine|November 9, 2017
New trends in antitumor vaccines in melanomaMarcos Vasquez, Shirley Tenesaca, Pedro Berraondo
Methods in Enzymology|March 4, 2020
Production and use of adeno-associated virus vectors as tools for cancer immunotherapyMyriam Fernandez-Sendin, Shirley Tenesaca, Marcos Vasquez, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2015
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cellsJosé Medina-Echeverz, Marcos Vasquez, Celia Gomar, et al.
Oncotarget|December 29, 2016
Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor modelMarcos Vasquez, Vladimir Paredes-Cervantes, Fernando Aranda, et al.
European Journal of Immunology|May 16, 2017
Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1Marcos Vasquez, Inês Simões, Marta Consuegra-Fernández, et al.
International Journal of Pediatric Otorhinolaryngology|September 4, 2012
Palate abnormalities in Chilean patients with chromosome 22q11 microdeletion syndromeGuillermo Lay-Son, Mirta Palomares, M Luisa Guzman, et al.
Oncotarget|October 21, 2016
Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse modelAna M Contreras-Sandoval, María Merino, Marcos Vasquez, et al.
Oncoimmunology|June 23, 2017
Cellular immunotherapies for cancerPedro Berraondo, Sara Labiano, Luna Minute, et al.
Cancers|July 17, 2020
Radiosensitisation of Hepatocellular Carcinoma Cells by VandetanibSami Znati, Rebecca Carter, Marcos Vasquez, et al.
Molecular Nutrition & Food Research|June 26, 2020
Scavenger Receptor Class B Type I is Required for 25-Hydroxycholecalciferol Cellular Uptake and Signaling in Myeloid CellsShirley Tenesaca, Marcos Vasquez, Myriam Fernandez-Sendin, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of Translational Medicine|November 9, 2017
New trends in antitumor vaccines in melanomaMarcos Vasquez, Shirley Tenesaca, Pedro Berraondo
Methods in Enzymology|March 4, 2020
Production and use of adeno-associated virus vectors as tools for cancer immunotherapyMyriam Fernandez-Sendin, Shirley Tenesaca, Marcos Vasquez, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2015
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cellsJosé Medina-Echeverz, Marcos Vasquez, Celia Gomar, et al.
Oncotarget|December 29, 2016
Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor modelMarcos Vasquez, Vladimir Paredes-Cervantes, Fernando Aranda, et al.
European Journal of Immunology|May 16, 2017
Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1Marcos Vasquez, Inês Simões, Marta Consuegra-Fernández, et al.
International Journal of Pediatric Otorhinolaryngology|September 4, 2012
Palate abnormalities in Chilean patients with chromosome 22q11 microdeletion syndromeGuillermo Lay-Son, Mirta Palomares, M Luisa Guzman, et al.
Oncotarget|October 21, 2016
Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse modelAna M Contreras-Sandoval, María Merino, Marcos Vasquez, et al.
Oncoimmunology|June 23, 2017
Cellular immunotherapies for cancerPedro Berraondo, Sara Labiano, Luna Minute, et al.
Cancers|July 17, 2020
Radiosensitisation of Hepatocellular Carcinoma Cells by VandetanibSami Znati, Rebecca Carter, Marcos Vasquez, et al.
Molecular Nutrition & Food Research|June 26, 2020
Scavenger Receptor Class B Type I is Required for 25-Hydroxycholecalciferol Cellular Uptake and Signaling in Myeloid CellsShirley Tenesaca, Marcos Vasquez, Myriam Fernandez-Sendin, et al.
Pageof 2